國立高雄大學圖資館 |

登入

回首頁 到查詢結果 [ subject:"Metastasis." ]

Radiopharmaceuticals in the management of leptomeningeal metastasis

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Radiopharmaceuticals in the management of leptomeningeal metastasisedited by Franklin C.L. Wong.
其他作者:	Wong, Franklin C. L.
出版者:	Cham :Springer International Publishing :2022.
面頁冊數:	xi, 232 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Metastasis.
電子資源:	https://doi.org/10.1007/978-3-031-14291-8
ISBN:	9783031142918$q(electronic bk.)

Radiopharmaceuticals in the management of leptomeningeal metastasis
Radiopharmaceuticals in the management of leptomeningeal metastasis[electronic resource] /edited by Franklin C.L. Wong. - Cham :Springer International Publishing :2022. - xi, 232 p. :ill., digital ;24 cm.

Human Leptomeningeal Metastasis (LM)- Epidemiology and Challenges -- State of Art of LM Radiographic Diagnosis - Anatomic and Functional Imaging -- State of Art of LM Therapies: Intrathecal and Systemic approaches -- Current Practice of Radiation Therapy of LM -- Radionuclides in the Diagnosis and Therapy in Neuro-Oncology -- Radionuclide LM Therapy - Published Clinical Trial Findings -- Intrathecal LM Dosimetry Models- Radionuclides in CSF Spaces -- Human Radiation Dosimetry from Imaging- Guidance for Therapy -- Radiographic Assessment for Monitoring of LM Treatment -- Clinical Assessment for Monitoring of LM Treatment -- Logistic and Regulatory Aspects of Locoregional Radionuclide Therapy -- Radionuclides in the Management of LM- Challenges and Opportunities.

This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy. LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM. The scientific bases of using radionuclides inside human CSF and ablating LM will be discussed within the text, with results from established and completed clinical trials to explore optimal use of radionuclides to diagnose and treat LM. Many limitations of current practices of treating LM are also discussed, as well as potential avenues of overcoming these limitations. This book is an ideal guide for clinical researchers in the practice of treating leptomeningeal metastasis including radiologists, neurologists, oncologists and radiotherapists as well as their associates.

ISBN: 9783031142918$q(electronic bk.)

Standard No.: 10.1007/978-3-031-14291-8doiSubjects--Topical Terms:

345769
Metastasis.

LC Class. No.: RC269.5

Dewey Class. No.: 616.99407

Radiopharmaceuticals in the management of leptomeningeal metastasis
LDR:02875nmm a2200325 a 4500 001 633576
003 DE-He213
005 20221112145953.0
006 m d
007 cr nn 008maaau
008 230511s2022 sz s 0 eng d
020 $a 9783031142918$q(electronic bk.)
020 $a 9783031142901$q(paper)
024 7 $a 10.1007/978-3-031-14291-8 $2 doi
035 $a 978-3-031-14291-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC269.5
072 7 $a MMP $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKS $2 thema
082 0 4 $a 616.99407 $2 23
090 $a RC269.5 $b .R129 2022
245 0 0 $a Radiopharmaceuticals in the management of leptomeningeal metastasis $h [electronic resource] / $c edited by Franklin C.L. Wong.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xi, 232 p. : $b ill., digital ; $c 24 cm.
505 0 $a Human Leptomeningeal Metastasis (LM)- Epidemiology and Challenges -- State of Art of LM Radiographic Diagnosis - Anatomic and Functional Imaging -- State of Art of LM Therapies: Intrathecal and Systemic approaches -- Current Practice of Radiation Therapy of LM -- Radionuclides in the Diagnosis and Therapy in Neuro-Oncology -- Radionuclide LM Therapy - Published Clinical Trial Findings -- Intrathecal LM Dosimetry Models- Radionuclides in CSF Spaces -- Human Radiation Dosimetry from Imaging- Guidance for Therapy -- Radiographic Assessment for Monitoring of LM Treatment -- Clinical Assessment for Monitoring of LM Treatment -- Logistic and Regulatory Aspects of Locoregional Radionuclide Therapy -- Radionuclides in the Management of LM- Challenges and Opportunities.
520 $a This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy. LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM. The scientific bases of using radionuclides inside human CSF and ablating LM will be discussed within the text, with results from established and completed clinical trials to explore optimal use of radionuclides to diagnose and treat LM. Many limitations of current practices of treating LM are also discussed, as well as potential avenues of overcoming these limitations. This book is an ideal guide for clinical researchers in the practice of treating leptomeningeal metastasis including radiologists, neurologists, oncologists and radiotherapists as well as their associates.
650 0 $a Metastasis. $3 345769
650 0 $a Radiopharmaceuticals $x Therapeutic use. $3 939544
700 1 $a Wong, Franklin C. L. $3 889386
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-14291-8
950 $a Medicine (SpringerNature-11650)